Award recognizes her role leading the Wilkinson, Walsh + Eskovitz team to another victory
WASHINGTON – Litigation Daily selected Wilkinson Walsh + Eskovitz Founding Partner Alexandra Walsh as its Litigator of the Week for her role persuading a Philadelphia jury to find for the defense in a bellwether trial over the adequacy of the warning labels for the blood thinner Xarelto.
Walsh, along with partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas in August. The victory was the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation.
Read her Q&A with Lit Daily Editor Jenna Greene here.
Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less than three hours of deliberations. The court had previously granted summary judgment to Bayer and Janssen on Plaintiff’s claim that Xarelto was defectively designed.
The WW+E team worked alongside Lindsey Boney and Nick Danella of Bradley, who also served as counsel for Bayer, and Mike Zellers of Tucker Ellis LLP and Chanda Miller of Drinker Biddle, who served as trial counsel for Janssen.
The case is Cooney v. Janssen Pharmaceuticals Inc. et al., case number 160602012, in the Court of Common Pleas of Philadelphia County, Pennsylvania.